Search Results (10)

Background/Objectives: Fluoroscopy has been widely adopted in interventional pulmonology, as it facilitates real-time visualization of the bronchoscope, endobronchial ultrasound, and biopsy tools during procedures. The purpose of this study was to evaluate the effectiveness of radiation shields in minimizing scattered X-ray dose to the bronchoscopist in a phantom study and to determine the dose of scattered X-ray dose to medical staff with radiation shields in clinical application. Methods: An anthropomorphic torso phantom was positioned on the fluoroscopic table between the C-arm X-ray tube and the image detector to mimic bronchoscopic operations. Upper and lower body lead shields were used to examine the effectiveness of radiation shielding. Scatter radiation rates were assessed at a first operator location using real-time dosimeters with and without protective devices. In clinical application, the scattered X-ray dose of the first operator and main assistant was measured using wearable radiation dosimeters during 20 procedures. Results: In the phantom study, scattered radiation without shielding was 266.34 ± 8.86 μSv/h (glabella), 483.90 ± 8.01 μSv/h (upper thorax), 143.97 ± 8.20 μSv/h (hypogastrium), and 7.22 ± 0.28 μSv/h (ankle). The combination of upper and lower body lead shields reduced the scattered X-ray dose by 98.7%, 98.3%, 66.2%, and 79.9% at these levels, respectively. In clinical application, mean scattered X-ray dose rates were 0.14 ± 0.05 μSv/procedure (eye), 0.46 ± 0.51 μSv/procedure (chest), 0.67 ± 0.50 μSv/procedure (hypogastrium), and 1.57 ± 2.84 μSv/procedure (assistant’s wrist). Conclusions: The combination of radiation shields significantly reduced the scattered X-ray dose at the operator site in the phantom study. The scattered X-ray dose to medical staff during bronchoscopy can be kept at a low level with the aid of a shielding system. Full article

Background/Objectives: To evaluate the detectability of iodine in mediastinal lesions with photon counting CT (PCCT) compared to conventional CT (CCT) in a phantom study. Methods: Mediastinal lesions were simulated by five cylindrical inserts with diameters from 1 to 12 mm within a 10 cm solid water phantom that was placed in the mediastinal area of an anthropomorphic chest phantom with fat ring (QRM-thorax, QRM L-ring, 30 cm × 40 cm cross-section). Inserts were filled with iodine contrast at concentrations of 0.238 to 27.5 mg/mL. A clinical chest protocol at 120 kV on a high-end CCT (Somatom Force, Siemens Healthineers) was compared to the same protocol on a PCCT (Naeotom Alpha, Siemens Healthineers). Images reconstructed with a soft tissue kernel at 1 mm thickness and a 512 matrix served as a reference. For PCCT, we studied the result of reconstructing virtual mono-energetic images (VMIs) at 40, 50, 60 and 70 keV, reducing exposure dose up by 66%, reducing slice thickness to 0.4 and 0.2 mm, and increasing matrix size from 512 to 768 and 1024. Two observers with similar experience independently determined the smallest insert size for which iodine enhancement could still be detected. Consensus was reached when detectability thresholds differed between observers. Results: CTDIvol on PCCT and CCT was 3.80 ± 0.12 and 3.60 ± 0.01 mGy, respectively. PCCT was substantially more sensitive than CCT for detection of iodine in small mediastinal lesions: to detect a 3 mm lesion, 11.2 mg/mL iodine was needed with CCT, while only 1.43 mg/mL was required at 40 keV and 50 keV with PCCT. Moreover, dose reduced by 66% resulted in a comparable detection of iodine between PCCT and CCT for all lesions, except 3 mm. Detection increased from 11.2 mg/mL on CCT to 4.54 mg/mL on PCCT. A matrix size of 1024 reduced this detection threshold further, to 0.238 mg/mL at 40 and 50 keV. For 5 mm lesions, this detection threshold of 0.238 mg/mL was already achieved with a 512 matrix. Very small, 1 mm lesions did not profit from PCCT except if reconstructed with a 1024 matrix, which reduced the detection threshold from 27.5 mg/mL to 11.2 mg/mL. Reduced slice thickness decreased iodine detection of 3–12 mm lesions but not for 1 mm lesions. Conclusions: Iodine detectability with PCCT is at least equal to CCT for simulated mediastinal lesions of 1–12 mm, even at a dose reduction of 66%. Iodine detectability further profits from virtual monoenergetic images of 40 and 50 keV and increased reconstruction matrix. Full article

The aim of this phantom study was to assess the detectability and volumetric accuracy of pulmonary nodules on photon-counting detector CT (PCD-CT) at different low-dose levels compared to conventional energy-integrating detector CT (EID-CT). In-house fabricated artificial nodules of different shapes (spherical, lobulated, spiculated), sizes (2.5–10 mm and 5–1222 mm³), and densities (−330 HU and 100 HU) were randomly inserted into an anthropomorphic thorax phantom. The phantom was scanned with a low-dose chest protocol with PCD-CT and EID-CT, in which the dose with PCD-CT was lowered from 100% to 10% with respect to the EID-CT reference dose. Two blinded observers independently assessed the CT examinations of the nodules. A third observer measured the nodule volumes using commercial software. The influence of the scanner type, dose, observer, physical nodule volume, shape, and density on the detectability and volumetric accuracy was assessed by a multivariable regression analysis. In 120 CT examinations, 642 nodules were present. Observer 1 and 2 detected 367 (57%) and 289 nodules (45%), respectively. With PCD-CT and EID-CT, the nodule detectability was similar. The physical nodule volumes were underestimated by 20% (range 8–52%) with PCD-CT and 24% (range 9–52%) with EID-CT. With PCD-CT, no significant decrease in the detectability and volumetric accuracy was found at dose reductions down to 10% of the reference dose (p > 0.05). The detectability and volumetric accuracy were significantly influenced by the observer, nodule volume, and a spiculated nodule shape (p < 0.05), but not by dose, CT scanner type, and nodule density (p > 0.05). Low-dose PCD-CT demonstrates potential to detect and assess the volumes of pulmonary nodules, even with a radiation dose reduction of up to 90%. Full article

With the complexity and high demands on quality assurance (QA) of photon beam radiation therapy, end-to-end (E2E) QA is necessary to validate the entire treatment workflow from pre-treatment imaging to beam delivery. A polymer gel dosimeter is a promising tool for three-dimensional (3D) dose distribution measurement. The purpose of this study is to design a fast “one delivery” polymethyl methacrylate (PMMA) phantom with a polymer gel dosimeter for the E2E QA test of the photon beam. The one delivery phantom is composed of ten calibration cuvettes for the calibration curve measurement, two 10 cm gel dosimeter inserts for the dose distribution measurement, and three 5.5 cm gel dosimeters for the square field measurement. The one delivery phantom holder is comparable in size and shape to that of a human thorax and abdomen. In addition, an anthropomorphic head phantom was employed to measure the patient-specific dose distribution of a VMAT plan. The E2E dosimetry was verified by undertaking the whole RT procedure (immobilization, CT simulation, treatment planning, phantom set-up, imaged-guided registration, and beam delivery). The calibration curve, field size, and patient-specific dose were measured with a polymer gel dosimeter. The positioning error can be mitigated with the one-delivery PMMA phantom holder. The delivered dose measured with a polymer gel dosimeter was compared with the planned dose. The gamma passing rate is 86.64% with the MAGAT-f gel dosimeter. The results ascertain the feasibility of the one delivery phantom with a polymer gel dosimeter for a photon beam in E2E QA. The QA time can be reduced with the designed one delivery phantom. Full article

Background: This study investigates the effects of vertical off-centring, localiser direction, tube voltage, and phantom positioning (supine and prone) on computed tomography (CT) numbers and radiation dose. Methods: An anthropomorphic phantom was scanned using a Discovery CT750 HD—128 slice (GE Healthcare) scanner at different tube voltages (80, 120, and 140 kVp). Images employing 0° and 180° localisers were acquired in supine and prone positions for each vertical off-centring (±100, ±60, and ±30 mm from the iso-centre). CT numbers and displayed volume CT dose index (CTDIvol) were recorded. The relationship between dose variation and CT number was investigated. Results: The maximum changes in CT number between the two phantom positions as a function of vertical-off-centring were for the upper thorax 34 HU (0° localiser, 120 kVp), mid thorax 43 HU (180° localiser, 80 kVp), and for the abdominal section 31 HU (0° localiser, 80 kVp) in the prone position. A strong positive correlation was reported between the variation in dose and CT number (r = 0.969, p < 0.001); 95% CI (0.93, 0.99). Conclusions: Patient positioning demands an approach with a high degree of accuracy, especially in cases where clinical decisions depend on CT number accuracy for tissue lesion characterisation. Full article

To evaluate whether the contrast-to-noise ratio (CNR) of an iodinated contrast agent in virtual monoenergetic images (VMI) from the first clinical photon-counting detector (PCD) CT scanner is superior to VMI CNR from a dual-source dual-energy CT scanner with energy-integrating detectors (EID), two anthropomorphic phantoms in three different sizes (thorax and abdomen, QRM GmbH), in combination with a custom-built insert containing cavities filled with water, and water with 15 mg iodine/mL, were scanned on an EID-based scanner (Siemens SOMATOM Force) and on a PCD-based scanner (Siemens, NAEOTOM Alpha). VMI (range 40–100 keV) were reconstructed without an iterative reconstruction (IR) technique and with an IR strength of 60% for the EID technique (ADMIRE) and closest matching IR strengths of 50% and 75% for the PCD technique (QIR). CNR was defined as the difference in mean CT numbers of water, and water with iodine, divided by the root mean square value of the measured noise in water, and water with iodine. A two-sample t-test was performed to evaluate differences in CNR between images. A p-value < 0.05 was considered statistically significant. For VMI without IR and below 60 keV, the CNR of the PCD-based images at 120 and 90 kVp was up to 55% and 75% higher than the CNR of the EID-based images, respectively (p < 0.05). For VMI above 60 keV, CNRs of PCD-based images at both 120 and 90 kVp were up to 20% lower than the CNRs of EID-based images. Similar or improved performance of PCD-based images in comparison with EID-based images were observed for VMIs reconstructed with IR techniques. In conclusion, with PCD-CT, iodine CNR on low energy VMI (<60 keV) is better than with EID-CT. Full article

In order to assess coronary artery calcium (CAC) quantification reproducibility for photon-counting computed tomography (PCCT) at reduced tube potential, an anthropomorphic thorax phantom with low-, medium-, and high-density CAC inserts was scanned with PCCT (NAEOTOM Alpha, Siemens Healthineers) at two heart rates: 0 and 60–75 beats per minute (bpm). Five imaging protocols were used: 120 kVp standard dose (IQ level 16, reference), 90 kVp at standard (IQ level 16), 75% and 45% dose and tin-filtered 100 kVp at standard dose (IQ level 16). Each scan was repeated five times. Images were reconstructed using monoE reconstruction at 70 keV. For each heart rate, CAC values, quantified as Agatston scores, were compared with the reference, whereby deviations >10% were deemed clinically relevant. Reference protocol radiation dose (as volumetric CT dose index) was 4.06 mGy. Radiation dose was reduced by 27%, 44%, 67%, and 46% for the 90 kVp standard dose, 90 kVp 75% dose, 90 kVp 45% dose, and Sn100 standard dose protocol, respectively. For the low-density CAC, all reduced tube current protocols resulted in clinically relevant differences with the reference. For the medium- and high-density CAC, the implemented 90 kVp protocols and heart rates revealed no clinically relevant differences in Agatston score based on 95% confidence intervals. In conclusion, PCCT allows for reproducible Agatston scores at a reduced tube voltage of 90 kVp with radiation dose reductions up to 67% for medium- and high-density CAC. Full article

Background: Current diagnosis of Transthyretin-related Amyloidosis (ATTR) using bone scintigraphy is primarily based on visual scoring and semi-quantitative indices. With the introduction of new potential life-prolonging drugs for ATTR, a more precise quantification of myocardial amyloid burden is desirable for improved response prediction and therapy monitoring. Methods: At first, quantification experiments using an anthropomorphic thorax phantom were performed. Second, 32 patients underwent both planar whole body [^99mTc]- 3,3-Diphosphono-1,2-Propanodicarboxylic Acid (DPD)-scintigraphy and quantitative Single-Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) of the thorax. SPECT/CT standardized myocardial uptake values SUVpeak and SUVpeak normalized to bone uptake (nSUVpeak) were determined. Results: Phantom measurements showed a strong linear relationship between the activity in the myocardial insert and the measured activity (r = 0.9998, p = 0.01), but the measured activity was systematically underestimated by approximately 30%. Receiver operating characteristics (ROC) analysis revealed a 100% sensitivity and specificity at a cut-off of 3.1 for SUVpeak for the differentiation of both patient groups. Conclusion: SUV quantification of ATTR amyloid burden is feasible using novel SPECT/CT technology. With a SUVpeak cut-off of 3.1, patients with Perugini grade 2 and 3 could be clearly separated from those with Perugini grade 0 and 1. Besides ATTR diagnostics, quantification of amyloid deposits could potentially be used for therapy monitoring and prognostication in patients with cardiac ATTR. Full article

The European Directive 2013/59/Euratom focuses on the radiation protection and patient dosimetry. In particular, the dose absorbed by serial organs such as the spinal cord due to diagnostic exams plays a crucial role in the appraisal of medical exposure. In this work, a comparison between dose measurements performed with Gafchromic^TM XR-QA2 and TLD 100H is presented. The dosimeters—after a calibration procedure through an X-ray tube—were placed within the thorax region of an anthropomorphic phantom corresponding to the spinal cord area exposed to a thoracic CT procedure. The mean-dose value was measured with Gafchromic^TM first, and it was then compared to the dose value obtained with TLDs, resulting in a good agreement between the two dosimetric methodologies. Additionally, the results showed that—due to the usage of the automatic exposure control (EC) system—the discrepancy between the two methods is proportional to the current output of the CT system. Full article

A miniature fiber-optic dosimeter (FOD) system was fabricated using a plastic scintillating fiber, a plastic optical fiber, and a multi-pixel photon counter to measure real-time entrance surface dose (ESD) during radiation diagnosis. Under varying exposure parameters of a digital radiography (DR) system, we measured the scintillating light related to the ESD using the sensing probe of the FOD, which was placed at the center of the beam field on an anthropomorphic thorax phantom. Also, we obtained DR images using a flat panel detector of the DR system to evaluate the effects of the dosimeter on image artifacts during posteroanterior (PA) chest radiography. From the experimental results, the scintillation output signals of the FOD were similar to the ESDs including backscatter simultaneously obtained using a semiconductor dosimeter. We demonstrated that the proposed miniature FOD can be used to measure real-time ESDs with minimization of DR image artifacts in the X-ray energy range of diagnostic radiology. Full article